Bio-Rad Technologies: A Definite Avoid [Seeking Alpha]
Bio-Rad Laboratories, Inc. Class A (BIO)
Last bio-rad laboratories, inc. class a earnings: 2/13 04:15 pm
Check Earnings Report
US:NYSE Investor Relations:
bio-rad.com/en-us/corporate/investor-relations
Company Research
Source: Seeking Alpha
Summary The healthcare space is dominated by stories revolving around the “next big thing” – so perhaps I should not be surprised that Bio-Rad Laboratories ( BIO ) has not seen a lot of press, positive or negative, over the past several years. Top line growth has been stagnant for more than five years now, and margins have been under pressure as well as general and administrative costs rise. The company has been a perennial underperformer of comps within the healthcare equipment and supplies subsector, but that has changed over the past year, with Bio-Rad posting a rather meteoric rise over the past fifty-two weeks: 42%, versus a hair over 10% for its peer group. Are the reasons for the jump in share price valid, and more importantly, how does the future look for Bio-Rad Laboratories? Business Overview, Market Fundamentals and Concerns Founded in 1952, Bio-Rad was initially engaged in development and production of specialty chemicals used in the biochemical and pharmaceuti
Show less
Read more
Impact Snapshot
Event Time:
BIO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BIO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BIO alerts
High impacting Bio-Rad Laboratories, Inc. Class A news events
Weekly update
A roundup of the hottest topics
BIO
News
- Bio-Rad (BIO) Hurt by Softness in BioPharma and Competition [Yahoo! Finance]Yahoo! Finance
- Norovirus Diagnostics Market To Reach USD 130.4 Billion By 2032 | DataHorizzon Research [Yahoo! Finance]Yahoo! Finance
- Bio-Rad’s Chief Operating Officer Andrew Last to RetireBusiness Wire
- Recombinant Proteins Market Size Projected to Surge $6.47 Billion Growth by 2033, Exhibit a CAGR of 8% [Yahoo! Finance]Yahoo! Finance
- Bio-Rad Laboratories, Inc. (NYSE: BIO) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.MarketBeat
BIO
Earnings
- 2/15/24 - Beat
BIO
Sec Filings
- 4/17/24 - Form 3
- 4/10/24 - Form 8-K
- 3/27/24 - Form ARS
- BIO's page on the SEC website